Cargando…
Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function
Monocytes play a vital role in the development of cardiovascular diseases. Type 2 diabetes mellitus (T2DM) is a major CVD risk factor, and T2DM-induced aberrant activation and enhanced migration of monocytes is a vital pathomechanism that leads to atherogenesis. We recently reported the upregulation...
Autores principales: | Dorenkamp, Marc, Nasiry, Madina, Semo, Dilvin, Koch, Sybille, Löffler, Ivonne, Wolf, Gunter, Reinecke, Holger, Godfrey, Rinesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914555/ https://www.ncbi.nlm.nih.gov/pubmed/36766855 http://dx.doi.org/10.3390/cells12030513 |
Ejemplares similares
-
Hyperglycaemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2/SRC kinase signalling axis
por: Dorenkamp, Marc, et al.
Publicado: (2018) -
The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms
por: Semo, Dilvin, et al.
Publicado: (2023) -
Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase
por: Markovics, Adrienn, et al.
Publicado: (2020) -
Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase
Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022) -
Determination of the molecular reach of the protein tyrosine phosphatase SHP-1
por: Clemens, Lara, et al.
Publicado: (2021)